Patent ID: 11857555
Assignee: ANTARES PHARMA, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 4:
5. The aqueous pharmaceutical formulation of claim 1, comprising 134 mg/mL hydrocortisone sodium phosphate, 134.1 mg/mL hydrocortisone sodium phosphate, 134.2 mg/mL hydrocortisone sodium phosphate, 134.3 mg/mL hydrocortisone sodium phosphate, 134.4 mg/mL hydrocortisone sodium phosphate, 134.5 mg/mL hydrocortisone sodium phosphate, 134.6 mg/mL hydrocortisone sodium phosphate, 134.7 mg/mL hydrocortisone sodium phosphate, 134.8 mg/mL hydrocortisone sodium phosphate, 134.9 mg/mL hydrocortisone sodium phosphate, or 135 mg/mL hydrocortisone sodium phosphate.